Coexistence of Neuromyelitis Optica and Amyotrophic Lateral Sclerosis: A Case Report

Abstract

The occurrence of amyotrophic lateral sclerosis (ALS) and neuromyelitis optica (NMO) in a single patient is exceedingly rare. We report a case of a 54-year-old woman of East Asian descent with a prior diagnosis of ALS who developed an episode of unexplained hiccups and nausea and vomiting consistent with area postrema syndrome 3 months prior to the onset of acute transverse myelitis. Magnetic resonance imaging revealed abnormal T2 hyperintensity and gadolinium enhancement at the cervicomedullary junction with extension to C3. Imaging was also notable for nonenhancing central cord T2 hyperintensity from T6 to T8 suggesting previous demyelination. The patient’s cerebrospinal fluid analysis was mildly inflammatory. She was found to have a positive NMO/aquaporin-4 immunoglobulin G titer (cell-based assay) greater than 1:100 000, consistent with a diagnosis of NMO. The unusual coexistence of ALS and NMO prompts consideration of potential common pathological neuroinflammatory processes.

Keywords

amyotrophic lateral sclerosis neuromyelitis optica transverse myelitis

Get full access to this article

View all access options for this article.

References

Mehta

Kaye

Bryan

. Prevalence of amyotrophic lateral sclerosis—United States, 2012–2013. MMWR Surveill Summ. 2016;65(8):1–12. doi:10.15585/mmwr.ss6508a1.

Brooks

Miller

Swash

. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293–299.

Chio

Logroscino

Hardiman

. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10(5-6):310–323. doi:10.3109/17482960802566824.

Wingerchuk

Banwell

Bennett

. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–189. doi:10.1212/WNL.0000000000001729.

Flanagan

Cabre

Weinshenker

. Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum. Ann Neurol. 2016. doi:10.1002/ana.24617.

Uzawa

Mori

Kuwabara

. Neuromyelitis optica: concept, immunology and treatment. J Clin Neurosci. 2014;21(1):12–21. doi:10.1016/j.jocn.2012.12.022.

Asgari

Lillevang

Skejoe

. A population-based study of neuromyelitis optica in Caucasians. Neurology. 2011;76(18):1589–1595. doi:10.1212/WNL.0b013e3182190f74.

Borisow

Meyer

Paul

. Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship? BMJ Case Rep. 2013;2013. doi:10.1136/bcr-2012-007975.

Bonetti

Stegagno

Cannella

. Activation of NF-kappaB and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology. Am J Pathol. 1999;155(5):1433–1438.

10.

Migheli

Piva

Atzori

. c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 1997;56(12):1314–1322.

11.

Walker-Caulfield

Guo

Johnson

. NFκB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG. J Neuroinflammation. 2015;12:185. doi:10.1186/s12974-015-0403-8.

12.

Nicaise

Soyfoo

Authelet

. Aquaporin-4 overexpression in rat ALS model. Anat Rec (Hoboken). 2009;292(2):207–213. doi:10.1002/ar.20838.

13.

Nicaise

Mitrecic

Demetter

. Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res. 2009;1301:152–162. doi:10.1016/j.brainres.2009.09.018.

14.

Garbuzova-Davis

Sanberg

. Blood-CNS barrier impairment in ALS patients versus an animal model. Front Cell Neurosci. 2014;8:21. doi:10.3389/fncel.2014.00021.

15.

Pittock

Weinshenker

Lucchinetti

. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006;63(7):964–968. doi:10.1001/archneur.63.7.964.